TD Cowen raised the firm’s price target on BrightSpring Health (BTSG) to $65 from $60 and keeps a Buy rating on the shares. The firm updated its model following Q1 results and they view 1Q results as a continuation of the company’s strong execution across business lines.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health price target raised to $64 from $53 at Stephens
- BrightSpring Health price target raised to $65 from $55 at BTIG
- BrightSpring Health price target raised to $61 from $50 at Wells Fargo
- BrightSpring Health price target raised to $60 from $55 at KeyBanc
- BrightSpring Earnings Call Highlights Strong Growth Momentum